Skip to main content
Fuad El Rassi, MD, Hematology, Atlanta, GA, Grady Health System

FuadEl RassiMD

Hematology Atlanta, GA

Hematologic Oncology, Myeloproliferative Disorder Hematology-Oncology, Sickle Cell & Other Anemias

Associate Professor, Hematology and Medical Oncology, Emory Univ Sch of Med

Dr. El Rassi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. El Rassi's full profile

Already have an account?

Education & Training

  • Emory University School of Medicine
    Emory University School of MedicineFellowship, Hematology and Medical Oncology, 2011 - 2014
  • St Louis University School of Medicine
    St Louis University School of MedicineResidency, Internal Medicine, 2008 - 2011
  • American University of Beirut Faculty of Medicine
    American University of Beirut Faculty of MedicineClass of 2006

Certifications & Licensure

  • GA State Medical License
    GA State Medical License 2013 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Management Strategies and Satisfaction Levels in Patients with Sickle Cell Disease: Interim Results from the International Sickle Cell World Assessment Survey (SWAY)
    Fuad El-Rassi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Impact of Sickle Cell Disease Symptoms on PatientsÍ Daily Lives: Interim Results from the International Sickle Cell World Assessment Survey (SWAY)
    Fuad El-Rassi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

  • A Prospective Phase II, Open-Label, Single-Arm, Multicenter Study to Assess the Efficacy and Safety of SEG101 (Crizanlizumab) in Sickle Cell Disease Patients with Pria... 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019

Hospital Affiliations